Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies

Immunotherapies are at the forefront of the fight against cancers, and researchers continue to develop and test novel immunotherapeutic modalities. Ideal cancer immunotherapies induce a patient’s immune system to kill their own cancer and develop long-lasting immunity. Research has demonstrated a cr...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vloten, Jacob P., Santry, Lisa A., McAusland, Thomas M., Karimi, Khalil, McFadden, Grant, Petrik, James J., Wootton, Sarah K., Bridle, Byram W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369252/
https://www.ncbi.nlm.nih.gov/pubmed/30788384
http://dx.doi.org/10.1016/j.omtm.2019.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369252/
https://www.ncbi.nlm.nih.gov/pubmed/30788384
http://dx.doi.org/10.1016/j.omtm.2019.01.012

Ejemplares similares